Abstract
Genomics is in the process of introducing a number of fundamental transformations in the practices of modern biology and medicine, in the pharmaceutical industry, and in society and culture. The transformative powers of genomics/post-genomics have created a significant number of interrelated policy challenges, such as in the fields of patenting, genetic testing and genetic information. Today a 'cultural vacuum' seems to exist, which tends to give room for a broad variety of speculations about the meaning and goals of genomics. So far, the new topics of genomics governance have not been taken up adequately in the already operating or emerging institutional structures of policy making. There exists a gap between policy challenges and institutional responses that might lead to growing social opposition against genomics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
